Media Alert: New Clinical Findings on Efficacy and Safety of Negative Pressure Wound Therapy to Be Presented at Fall 2010 Symposium on Advanced Wound…

ANAHEIM, CA–(Marketwire – September 22, 2010) – Leading wound care experts will present a Poster highlighting results from a multicenter randomized controlled trial (RCT) comparing negative pressure wound therapy (NPWT) between the SNaP® Wound Care System from Spiracur, Inc., of Sunnyvale, Calif., and the Wound V.A.C.® Therapy System from Kinetic Concepts, Inc. of San Antonio, Texas, for the treatment of chronic lower extremity ulcers. The Poster will be presented at the Fall 2010 Symposium on Advanced Wound Care (SAWC) in Anaheim, Calif.

Background:  The SNaP Wound Care System is an ultraportable and disposable NPWT device that was approved by the U.S. Food & Drug Administration (FDA) in August 2009 in a new technology category the FDA defined as “non-powered” NPWT devices. It is currently available for purchase in the U.S. The new system produces the same level of negative pressure as competitive technologies; however, it requires no electric or battery power making treatment completely silent. In addition, the therapy system weighs less than three ounces, enabling patients to wear the device under clothing and resume daily activity during the course of treatment.

About Spiracur, Inc.
Spiracur, Inc. is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford Biodesign Innovation program in 2007. Its first product, the SNaP Wound Care System, grew out of the notion that current negative pressure wound therapies were too cumbersome for patients and clinicians. Spiracur strives to develop products that are truly patient-centric. For more information, please visit http://www.spiracur.com.

SNaP and Spiracur are registered trademarks of Spiracur, Inc.